{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:41:55Z","timestamp":1791186115528,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Republic of Cyprus"},{"name":"Research and Innovation Foundation","award":["EXCELLENCE\/0918\/0093"],"award-info":[{"award-number":["EXCELLENCE\/0918\/0093"]}]},{"name":"Ministry of Health of the Republic of Cyprus","award":["240\/2019"],"award-info":[{"award-number":["240\/2019"]}]},{"DOI":"10.13039\/100012996","name":"University of Cyprus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.meegid.2020.104243","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T02:36:15Z","timestamp":1581561375000},"page":"104243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Development of a new comprehensive HIV-1 genotypic drug resistance assay for all commercially available reverse transcriptase, protease and integrase inhibitors in patients infected with group M HIV-1 strains"],"prefix":"10.1016","volume":"81","author":[{"given":"Andreas C.","family":"Chrysostomou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9641-7737","authenticated-orcid":false,"given":"Cicek","family":"Topcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora C.","family":"Stylianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johana","family":"Hezka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5340-7109","authenticated-orcid":false,"given":"Leondios G.","family":"Kostrikis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2020.104243_bb0005","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1128\/JVI.00302-14","article-title":"Mutations in HIV-1 reverse transcriptase affect the errors made in a single cycle of viral replication","volume":"88","author":"Abram","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2020.104243_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcv.2017.04.012","article-title":"HIV-1 integrase inhibitor resistance among treatment na\u00efve patients in the West of Scotland","volume":"92","author":"Bradley-Stewart","year":"2017","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.meegid.2020.104243_bb0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jviromet.2016.04.007","article-title":"Detecting primary drug-resistant mutations in Korean HIV patients using ultradeep pyrosequencing","volume":"234","author":"Cho","year":"2016","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.meegid.2020.104243_bb0020","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01443-18","article-title":"Limited marginal utility of deep sequencing for HIV drug resistance testing in the age of integrase inhibitors","author":"Dalmat","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2020.104243_bb0025","author":"European Centre for Disease Prevention and Control"},{"key":"10.1016\/j.meegid.2020.104243_bb0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000445852","article-title":"Human immunodeficiency virus (HIV)","volume":"43","author":"German Advisory Committee Blood (Arbeitskreis Blut), S. \u2018Assessment of P.T. by B","year":"2016","journal-title":"Transfus. Med. Hemother."},{"key":"10.1016\/j.meegid.2020.104243_bb0035","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0166-0934(97)00072-4","article-title":"Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes","volume":"66","author":"Gobbers","year":"1997","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.meegid.2020.104243_bb0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1086\/589297","article-title":"Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an international AIDS society-USA panel","volume":"47","author":"Hirsch","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2020.104243_bb0045","doi-asserted-by":"crossref","first-page":"e433","DOI":"10.1016\/S2352-3018(17)30109-1","article-title":"Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV\/AIDS: a systematic review and network meta-analysis","volume":"4","author":"Kanters","year":"2017","journal-title":"Lancet HIV"},{"key":"10.1016\/j.meegid.2020.104243_bb0050","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/bioinformatics\/bts199","article-title":"Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data","volume":"28","author":"Kearse","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.meegid.2020.104243_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/aid.2008.0168","article-title":"Genetic analysis of HIV type 1 strains from newly infected untreated patients in Cyprus: high genetic diversity and low prevalence of drug resistance","volume":"25","author":"Kousiappa","year":"2009","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.meegid.2020.104243_bb0060","doi-asserted-by":"crossref","DOI":"10.1093\/molbev\/msy096","article-title":"MEGA X: molecular evolutionary genetics analysis across computing platforms","author":"Kumar","year":"2018","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.meegid.2020.104243_bb0065","author":"Los Alamos National Laboratories"},{"key":"10.1016\/j.meegid.2020.104243_bb0070","article-title":"PANDAA-monium: intentional violations of conventional qPCR design enables rapid, HIV-1 subtype-independent drug resistance SNP detection","volume":"795054","author":"MacLeod","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.meegid.2020.104243_bb0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jviromet.2004.02.005","article-title":"Performance of ViroSeq HIV-1 genotyping system in routine practice at a Belgian clinical laboratory","volume":"119","author":"Maes","year":"2004","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.meegid.2020.104243_bb0080","first-page":"1518","article-title":"Performance characteristics of a modified HIV-1 drug resistance genotyping method for use in resource-limited settings. F1000","volume":"8","author":"Magomere","year":"2019","journal-title":"Research"},{"key":"10.1016\/j.meegid.2020.104243_bb0085","series-title":"Laboratory diagnosis of HIV-1 infections: state of the art BT - advanced techniques in diagnostic microbiology: Volume 2: Applications","first-page":"445","author":"Nguyen","year":"2018"},{"key":"10.1016\/j.meegid.2020.104243_bb0090","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.meegid.2013.04.032","article-title":"Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools","volume":"19","author":"Pineda-Pe\u00f1a","year":"2013","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.meegid.2020.104243_bb0095","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/s41598-017-19080-5","article-title":"HIV-1 infection in Cyprus, the eastern Mediterranean European frontier: A densely sampled transmission dynamics analysis from 1986 to 2012","volume":"8","author":"Pineda-Pe\u00f1a","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.meegid.2020.104243_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-14-317","article-title":"Automated analysis of phylogenetic clusters","author":"Ragonnet-Cronin","year":"2013","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.meegid.2020.104243_bb0105","doi-asserted-by":"crossref","first-page":"104229","DOI":"10.1016\/j.jcv.2019.104229","article-title":"Performance evaluation of the Vela Dx Sentosa next-generation sequencing system for HIV-1 DNA genotypic resistance","volume":"122","author":"Raymond","year":"2020","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.meegid.2020.104243_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198246","article-title":"Genotyping performance evaluation of commercially available HIV-1 drug resistance test","volume":"13","author":"Rosemary","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2020.104243_bb0115","doi-asserted-by":"crossref","first-page":"e81355","DOI":"10.1371\/journal.pone.0081355","article-title":"Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada","volume":"8","author":"Samji","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2020.104243_bb0120","first-page":"91","article-title":"Clinical relevance of genotypic resistance testing today","volume":"39","author":"Santoro","year":"2016","journal-title":"New Microbiol."},{"key":"10.1016\/j.meegid.2020.104243_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224292","article-title":"Comparison of an in-house \u2018home-brew\u2019 and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples","volume":"14","author":"Seatla","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2020.104243_bb0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12981-018-0206-y","article-title":"Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism assay","volume":"15","author":"Silver","year":"2018","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.meegid.2020.104243_bb0135","doi-asserted-by":"crossref","DOI":"10.1159\/000331998","article-title":"The HIVdb system for HIV-1 genotypic resistance interpretation","author":"Tang","year":"2012","journal-title":"Intervirology."},{"key":"10.1016\/j.meegid.2020.104243_bb0140","doi-asserted-by":"crossref","first-page":"8970","DOI":"10.1038\/s41598-019-45328-3","article-title":"A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance","volume":"9","author":"Taylor","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.meegid.2020.104243_bb0145","doi-asserted-by":"crossref","DOI":"10.1097\/QAD.0000000000002105","article-title":"Caution is needed in interpreting HIV transmission chains by ultradeep sequencing","author":"Todesco","year":"2019","journal-title":"AIDS."},{"key":"10.1016\/j.meegid.2020.104243_bb0150","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00105-18","article-title":"Comparison of an in vitro diagnostic next-generation sequencing assay with sanger sequencing for HIV-1 genotypic resistance testing","author":"Tzou","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2020.104243_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2015.06.001","article-title":"HIV-1 genotypic drug resistance testing: digging deep, reaching wide?","author":"Van Laethem","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.meegid.2020.104243_bb0160","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jviromet.2009.11.011","article-title":"Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1","volume":"163","author":"Wallis","year":"2010","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.meegid.2020.104243_bb0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jviromet.2016.12.008","article-title":"Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes","volume":"241","author":"Wallis","year":"2017","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.meegid.2020.104243_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmoldx.2019.06.003","article-title":"Prospective evaluation of the vela diagnostics next-generation sequencing platform for HIV-1 genotypic resistance testing","author":"Weber","year":"2019","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.meegid.2020.104243_bb0175","author":"World Health Organization"},{"key":"10.1016\/j.meegid.2020.104243_bb0180","author":"World Health Organization"},{"key":"10.1016\/j.meegid.2020.104243_bb0185","article-title":"Complete genome sequence of CG-0018a-01 establishes HIV-1 subtype L","author":"Yamaguchi","year":"2019","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.meegid.2020.104243_bb0190","doi-asserted-by":"crossref","DOI":"10.2174\/1570162X17666190927154110","article-title":"Genotypic methods for HIV drug resistance monitoring: the opportunities and challenges faced by China","author":"Zuo","year":"2019","journal-title":"Curr. HIV Res."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134820300757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134820300757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:40:49Z","timestamp":1761576049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134820300757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":38,"alternative-id":["S1567134820300757"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2020.104243","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a new comprehensive HIV-1 genotypic drug resistance assay for all commercially available reverse transcriptase, protease and integrase inhibitors in patients infected with group M HIV-1 strains","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2020.104243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104243"}}